JPMorgan lowered the firm’s price target on GSK (GSK) to 1,440 GBp from 1,550 GBp and keeps an Underweight rating on the shares.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter